Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics（2017）
Key words
Hepatocellular carcinoma (HCC),Sorafenib,Matrix metalloproteinase-2 (MMP-2),SB-3CT,PI3K/AKT/mTOR pathway
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined